Startups

XiFin: Strategic Growth Investment Raised And Jeff Margolis Joins Board

By Amit Chowdhry ● Sep 3, 2025

XiFin, a leader in the field of revenue cycle management and billing solutions, has announced several exciting developments. The company has recently secured a new round of growth capital to support its ongoing expansion and innovation. In addition, XiFin has welcomed Jeff Margolis, a renowned figure in healthcare information technology and a visionary futurist, to its Board of Directors.

Treeline Biosciences: $200 Million Additional Funding Raised And First Clinical Trials Announced

By Amit Chowdhry ● Sep 3, 2025

Treeline Biosciences, a company at the forefront of innovative cancer research, recently announced significant progress in its clinical development. They have started Phase 1 trials for three promising programs, two of which are internally discovered, and one is an in-licensed project. The internal programs include a BCL6 degrader and an EZH2 inhibitor, both of which target lymphoma. The third program is a pan-KRAS inhibitor aimed at various cancers with specific KRAS mutations. The company also recently closed a $200 million extension of its Series A funding round, bringing its total raised capital to over $1.1 billion.

IQM Quantum Computers: Over $300 Million Series B Raised To Expand Globally

By Amit Chowdhry ● Sep 3, 2025

IQM Quantum Computers, a company in the realm of full-stack superconducting quantum computers, has announced a significant milestone in its journey. The company raised $320 million (equivalent to €275 million) in a Series B round of funding. This funding brings IQM's total funding to date to $600 million.

Intella: $12.5 Million Series A Raised For Arabic Speech Intelligence Platform

By Amit Chowdhry ● Sep 3, 2025

Prosus Ventures announced that it has led a $12.5 million Series A funding round in Intella. Intella has established itself as a market leader in dialectal Arabic speech intelligence. This area holds considerable potential due to the linguistic diversity and complexity of the Arab world. The funding round also saw participation from several notable investors, including 500 Global, Waed Ventures, Hala Ventures, Idrisi Ventures, and HearstLab, the investment branch of Hearst Corporation. As a result of this infusion of capital, Intella’s total funding now stands at approximately $16.9 million.

CHARM Therapeutics: $80 Million Series B Raised For Next-Generation AML Treatment

By Amit Chowdhry ● Sep 3, 2025

CHARM Therapeutics has closed an oversubscribed Series B funding round, raising a substantial $80 million. This capital will be instrumental in propelling their innovative menin inhibitor into clinical testing. The funding attracted a diverse group of global investors, including previous supporters and new partners, demonstrating their strong confidence in CHARM's approach. The company’s strategy centers on overcoming the resistance issues that have limited the effectiveness of earlier menin inhibitors—a significant step forward in treating acute myeloid leukemia.

Anthropic: $13 Billion Series F Raised At $183 Billion Valuation To Advance AI Products

By Amit Chowdhry ● Sep 3, 2025

Anthropic has completed a Series F fundraising of $13 billion led by ICONIQ. This funding values Anthropic at $183 billion post-money. Along with ICONIQ, the round was co-led by Fidelity Management & Research Company and Lightspeed Venture Partners. Significant investors in this round include Altimeter, Baillie Gifford, affiliated funds of BlackRock, Blackstone, Coatue, D1 Capital Partners, General Atlantic, General Catalyst, GIC, Growth Equity at Goldman Sachs Alternatives, Insight Partners, Jane Street, Ontario Teachers' Pension Plan, Qatar Investment Authority, TPG, T. Rowe Price Associates, T. Rowe Price Investment Management, WCM Investment Management, and XN. Anthropic has seen rapid growth since the launch of Claude in March 2023.